←
Rasmus Bech Hansen953 posts
Rasmus Bech Hansen avatar

Rasmus Bech Hansen

@rasbech

@airfinity co-founder

◷ Joined March 2009▧ 36 Photos and videos
Airfinity avatar
⟳ Rasmus Bech Hansen retweeted
Airfinity@Airfinity·14 Jun 2021

Congratulations to the @nytimes on the Public Service #Pulitzer Award! The need for real-time, reliable data has never been more pressing and the pandemic has shown how critical independent quality #journalism is to better decision making and public trust.

The staff of The New York Times has won the Pulitzer Prize for Public Service for coverage of the pandemic. Here are the award-winning pieces. nyti.ms/3xfE1ct

Post attachment
Airfinity avatar
⟳ Rasmus Bech Hansen retweeted
Airfinity@Airfinity·25 Mar 2021

.@TheLancetInfDis reports on the hope for #Europe to reach #immunisation by the end of Summer including @Airfinity insights predicting some countries reaching that level of protection only later this year. thelancet.com/journals/lanin…

Airfinity avatar
⟳ Rasmus Bech Hansen retweeted
Airfinity@Airfinity·24 Mar 2021

Our #COVID19 vaccine insight of the day is our view on total doses produced and the number of doses that have actually been exported across countries/regions.

Post attachment
Sam Joiner avatar
⟳ Rasmus Bech Hansen retweeted
Sam Joiner@samjoiner·13 Mar 2021

The enormous return on investment reflects the immense scale of the damage caused by the pandemic, @rasbech told @thetimes. “Vaccine production costs billions. But you get benefits in the order of trillions, so it’s worth doing.” 7/7 Read the full story: thetimes.co.uk/article/brita…

Rasmus Bech Hansen avatar
Rasmus Bech Hansen@rasbech·11 Feb 2021

Glad to take part here. Scaleable, globally deployable mRNA production could be an important part of the solution to the current supply constraints.

We cannot vaccinate the world until the end of 2022, raising the risk of further dangerous variants and endemic Covid-19, warns @rasbech of @airfinity Endemic Covid raises the challenge of annually vaccinating the whole world. Full interview at: youtu.be/kVIDPjnsVak

Rasmus Bech Hansen avatar
Rasmus Bech Hansen@rasbech·29 Jan 2021

The unexpected parts of J&J and Novovax’ vaccine results are the high impact of the new variants. Big implications for the world.

Rasmus Bech Hansen avatar
Rasmus Bech Hansen@rasbech·26 Jan 2021

Glad that @Airfinity is collaborating with the brilliant C-19 team at the @FinancialTimes. I think the many journalists working day and night to accurately inform the public in a sea of misinformation are among the unsung heroes of this pandemic and we are proud to support them.

How should countries and international bodies build an effective vaccine responses? Our data suggests a broad range of accelerated public investments in trials, manufacturing, supply chain security and multi-technology investments are critical. Important piece in @FT .

Post attachment
Rasmus Bech Hansen avatar
Rasmus Bech Hansen@rasbech·13 Dec 2020

Thank you for sharing @Airfinity data @EricTopol . With flurry of vaccine deals this changes daily. Here are numbers as of today (13th Dec). Happy to share more details. public.flourish.studio/story…

Eric Topol@EricTopol12 Dec 2020

Before the vaccine problems with Sanofi-GSK (wrong dose) and Astra Zeneca/Oxford (? dose) the US was already short in covering its population nature.com/articles/d41586-0… /2

Post attachment